Consolidated Investment Group LLC Vertex Pharmaceuticals Inc Transaction History

Consolidated Investment Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$221.42 - $260.97 $619,976 - $730,716	-2,800 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $3.47 Million - $4.38 Million	-19,600 Reduced 87.5%	2,800 $615,000
Q2 2021 Jul 22, 2021	BUY	$187.49 - $221.1 $562,470 - $663,300	3,000 Added 15.46%	22,400 $4.52 Million
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $1.32 Million - $1.54 Million	6,400 Added 49.23%	19,400 $4.17 Million
Q4 2020 Jan 19, 2021	BUY	$207.01 - $276.09 $2.69 Million - $3.59 Million	13,000 New	13,000 $3.07 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Consolidated Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Consolidated Investment Group LLC with notifications on news.